il 19,
2021) – A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
The study, recently published in Diagnostics, demonstrates artesunate, synthesized from Artemisia annua, kills ovarian cancer cells in multiple preclinical model systems.
Despite accounting for only 1.3% of all new cancer cases, 2.3% of cancer deaths in 2021 are predicted to be caused by ovarian cancer. The current standard of care for advanced ovarian cancer, which hasn’t changed since 2003, is the use of two chemotherapy agents: carboplatin and paclitaxel.
In this study, the researchers determined that artesunate, both alone and in combination with carboplatin and paclitaxel, has anticancer activity at concentrations that are achievable in the clinic, which support the further clinical development of this strategy.
Pete Comparoni | UK Photo.
LEXINGTON, Ky. (April 7, 2021) It’s a mission the University of Kentucky strives to live up to each and every day – to be the University of, for and with Kentucky.
Now, you can be part of that mission to meet this unprecedented moment and help create a healthier, safer community.
Kentuckians, regardless of the phase they fall into, are encouraged to request an appointment for a COVID-19 vaccine through UK’s vaccination clinic at vaccine.ukhc.org.
The need is significant: The numbers of new COVID-19 cases have plateaued this week in Kentucky after multiple weeks of declines. Incidence rates are up across much of the country and around the world. A vaccine is the best defense against a re-emergence or surge of the virus.
LEXINGTON, Ky. (March 15, 2021) Do you want to expand your understanding of diversity and inclusivity? It is time to talk about intersectionality with the University of Kentucky Women’s Forum. The March professional development session and monthly “Coffee and Connect” programming will explore the concept and history of intersectionality, help you to recognize your own intersectional identities, and provide strategies for incorporating intersectionality into diversity and inclusivity initiatives.
From 11 a.m. to noon Tuesday, March 16, on Zoom, Demetria McDonald, founder and CEO of Decide Diversity, will discuss intersectionality. McDonald works with groups across the country to improve diversity and inclusion practices that positively impact business results. In 2019, she received Young Leader of Louisville recognition from Louisville Business First. Decide Diversity is a company focused on increasing the presence and effectiveness of underrepresented groups in the wo
LEXINGTON, Ky. (March 8, 2021) – More than 700,000 people across Kentucky are fully vaccinated against COVID-19, after receiving both doses of the Pfizer or Moderna vaccines. The number continues to grow each day, especially as the rollout of the single-dose Johnson & Johnson vaccine began last week.
At UK HealthCare, hundreds of medical, professional and volunteer personnel are part of the collective effort making this possible.
The COVID-19 vaccines were created faster than any other in history. While it may seem that the process was rushed, Brooke Hudspeth, Pharm.D., associate professor, UK College of Pharmacy’s Department of Pharmacy Practice and Science, said the technology to develop the vaccines has been around for many years. Still, questions and uncertainty surrounding their safety and efficacy remain.
of
LEXINGTON, Ky. (March 5, 2021) Throughout the month of March, the University of Kentucky will recognize Women’s History Month with a series of events and special programs.
Women’s History Month is about honoring the achievements and contributions women have made across the U.S. and throughout the world. The UK Martin Luther King (MLK) Center will host a variety of programs, in collaboration with its campus partners, in addition to the College of Arts and Sciences, the UK Women’s Forum, the National Pan-Hellenic Council (NPHC) and other campus organizations.
Many programs will honor UK women throughout the institution s history.